NCT00555646View on ClinicalTrials.gov

Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Plaque Psoriasis
Interventions
DRUG

PH-10 (rose bengal disodium 0.001%)

Treatment plaque area 1: PH-10 with 544 nm LED light illumination.

DRUG

PH-10 (rose bengal disodium 0.001%)

Treatment plaque area 2: PH-10 with ambient light illumination.

DRUG

Control

No treatment control.

Trial Locations (1)

10029

Mount Sinai School of Medicine, New York

Sponsors
All Listed Sponsors
lead

Provectus Pharmaceuticals

INDUSTRY